1. Home
  2. VCIG vs GCTK Comparison

VCIG vs GCTK Comparison

Compare VCIG & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VCI Global Limited

VCIG

VCI Global Limited

HOLD

Current Price

$4.80

Market Cap

2.9M

ML Signal

HOLD

Logo GlucoTrack Inc.

GCTK

GlucoTrack Inc.

HOLD

Current Price

$0.39

Market Cap

3.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VCIG
GCTK
Founded
2013
2001
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9M
3.0M
IPO Year
2022
2011

Fundamental Metrics

Financial Performance
Metric
VCIG
GCTK
Price
$4.80
$0.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.6M
601.2K
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.65
Revenue
N/A
$589,462.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$1.81
$0.14
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$0.29
52 Week High
$23.40
$15.90

Technical Indicators

Market Signals
Indicator
VCIG
GCTK
Relative Strength Index (RSI) 50.91 30.39
Support Level $0.70 $0.29
Resistance Level $11.58 $1.02
Average True Range (ATR) 1.76 0.07
MACD -0.35 -0.01
Stochastic Oscillator 8.40 19.08

Price Performance

Historical Comparison
VCIG
GCTK

About VCIG VCI Global Limited

VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.

Share on Social Networks: